Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis

Abstract Background The number of patients treated with extracorporeal membrane oxygenation (ECMO) devices is increasing. Anticoagulation therapy is crucial to prevent thrombosis during ECMO therapy. Predominantly, heparin has been used as primary anticoagulant but direct thrombin inhibitors (DTI) h...

Descrizione completa

Dettagli Bibliografici

Autori principali:	René M’Pembele, Sebastian Roth, Aljoscha Metzger, Anthony Nucaro, Alexandra Stroda, Amin Polzin, Markus W. Hollmann, Giovanna Lurati Buse, Ragnar Huhn
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2022-07-01
Serie:	Thrombosis Journal
Soggetti:	Bivalirudin Argatroban Anticoagulation Bleeding Thrombosis Mechanical circulatory support
Accesso online:	https://doi.org/10.1186/s12959-022-00401-2
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!